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Abstract
Background: HTRA3 is a recently identified member of the mammalian serine protease family HTRA
(high temperature requirement factor A). In both the rodent and the human HTRA3 is transcribed into
two mRNA species (long and short) through alternative splicing. We have previously shown that HTRA3
is expressed in the mature rat ovary and may be involved in folliculogenesis and luteinisation. HTRA3 is
also upregulated during mouse and human placental development. The current study investigated whether
HTRA3 is also localised in the primate ovary (rhesus monkey n = 7). In addition, we examined the non-
pregnant rhesus monkey endometrium (n = 4) and maternal-fetal interface during early pregnancy (n = 5)
to further investigate expression of HTRA3 in primate endometrium and placentation.
Methods: HTRA3 mRNA levels in several rhesus monkey tissues was determined by semiquantitative RT-
PCR. Protein expression and localisation of HTRA3 was determined by immunohistochemistry.
Results: Long and short forms of HTRA3 mRNA were detected in the ovary, aorta, bladder, small
intestine, skeletal muscle, heart and uterus but not the liver nor the kidney. HTRA3 protein was
immunolocalised to the oocyte of all follicular stages in the rhesus monkey ovary. Protein expression in
mural and cumulus granulosa cells of late secondary follicles increased significantly compared to granulosa
cells of primordial, primary and secondary follicles. Mural and cumulus granulosa cells of antral follicles also
showed a significant increase in expression. Staining intensity was higher in the granulosa-lutein cells
compared to the theca-lutein cells of corpora lutea (n = 3). In the non-pregnant monkey endometrium,
HTRA3 was detected in the glandular epithelium. The basalis endometrial glands showed higher staining
intensity than functionalis endometrial glands. During early pregnancy, strong staining for HTRA3 protein
was seen in both maternal decidual cells and glands.
Conclusion: We propose that HTRA3 may be involved in folliculogenesis and luteinisation in the primate
ovary. Furthermore, similar to previous findings in the human, HTRA3 is possibly a factor involved in and
potentially important for primate placentation.
Published: 18 June 2008
Reproductive Biology and Endocrinology 2008, 6:22 doi:10.1186/1477-7827-6-22
Received: 8 March 2008
Accepted: 18 June 2008
This article is available from: http://www.rbej.com/content/6/1/22
© 2008 Bowden et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Reproductive Biology and Endocrinology 2008, 6:22 http://www.rbej.com/content/6/1/22
Page 2 of 11
(page number not for citation purposes)
Background
The high temperature requirement factor A (HtrA) family
of serine proteases was first identified in E. coli and is con-
served from bacteria to humans [1,2]. We identified and
cloned a novel gene that is considerably upregulated in
the mouse uterus in association with placentation [3].
After cloning the full mRNA sequence of this gene in the
human [4] [accession number NM_053044.2, GenBank®
Identifier (GI) 24475740] we determined that this pro-
tease was structurally related to the previously identified
mammalian proteases HTRA1 and 2. Consequently we
named this new gene HTRA3 [4]. In the human and the
rodent, HTRA3 gene undergoes alternative splicing (long
and short mRNA forms) [3-5]. In both the human and the
rodent, the HTRA3  gene consists of 10 exons. Long
HTRA3 is produced by utilizing exons 1 through to 10
except exon 7, whilst the short form is produced by utiliz-
ing exons 1 through to 7 [3-5].
The alternative splicing of the HTRA3 gene into the long
and short form mRNA results in two predicted protein iso-
forms in both the human and the rodent, 49 kDa and 38
kDa respectively [3,4]. Mammalian HTRA1 and 3 share
similar domain organisation including a highly conserved
trypsin-like serine protease domain and a C-terminal
postsynaptic density protein 95-Discs large-Zona
occuldens 1 (PDZ) domain that mediates specific protein-
protein interactions. Mammalian HTRA3 also consists of
an N-terminal signal peptide, an insulin growth factor
binding domain and a kazal-type S protease inhibitor
domain [4,6]. Whilst HTRA3 is a serine protease, that fact
that it contains an insulin-like growth factor (IGF) bind-
ing domain at the N-terminal following the signal pep-
tide, suggests that it can be secreted and may be involved
in the IGF system.
In both the human and the rodent, the protein sequence
of short HTRA3 is identical to that of the long except that
it contains exon 7, whilst long form HTRA3 mRNA does
not, and it lacks the C-terminal PDZ domain [4,5]. HTRA3
is well conserved between human, mouse and rat with
identical bases at 87% and 79% for the mouse and the rat
mRNA respectively and 95% similarity for both at the pro-
tein level [5,7].
Northern analysis has shown high expression of HTRA3
mRNA in the mouse ovary [3]. In the rat, we have shown
a significant increase of long form HTRA3 mRNA expres-
sion from immature to mature state ovaries [5]. When
HTRA3 protein expression was investigated throughout
the rat estrous cycle, it was upregulated in the cumulus
and mural granulosa cells of late secondary, antral and
preovulatory follicles. High levels of HTRA3 protein were
also localized in the corpora lutea (CL) [5]. Furthermore
long HTRA3 mRNA increased significantly with FSH treat-
ment of rat primary granulosa cells in culture for 16 h
compared to control, concurrent with luteinisation in
vitro.
HTRA3 was first identified as a pregnancy related serine
protease, uniquely regulated at the time of implantation
and placentation in the mouse and human [3,7]. HTRA3
protein has been immunolocalised predominantly to the
decidua basalis during mouse implantation [8]. In human
endometrium, both glandular and decidual expression of
HTRA3 increased significantly in early pregnancy com-
pared to normal endometrium [7]. In particular, decidual
expression significantly increased during the first-trimes-
ter pregnancy when decidualisation advanced. Further-
more, HTRA3 protein was significantly elevated in the
serum of women in first-trimester pregnancy [7]. It has
also been reported that there is a clear association between
HTRA3 and the human menstrual cycle. The endometrial
expression of HTRA3 was found to be highest at the late
secretory phase of the cycle, when the endometrium is
prepared for maternal-trophoblast interaction should fer-
tilisation occur [7].
In the present study we investigated the expression and
regulation of HTRA3 mRNA and protein in the non-preg-
nant rhesus monkey ovary and endometrium, and at the
maternal-fetal interface during early pregnancy. We pro-
pose that similar to the findings in the rodent, HTRA3
may be associated with folliculogenesis and luteinisation
in the primate ovary. In addition, HTRA3 is expressed in
the endometrium during the monkey menstrual cycle and
therefore may be associated with early pregnancy in the
primate.
Methods
Tissue collection and processing
Rhesus monkeys (Macaca mulatta) were maintained in the
Fu-Zhou Primate Research Centre, China. All experimen-
tal work was approved by the Animal Ethics Committee at
the Institute of Zoology, Chinese Academy of Sciences.
Menstrual cycles of female monkeys were monitored for
2–3 cycles before sampling (n = 10). One ovary and uter-
ine tissue were collected 3, 2 and 1 day before (ov-3, ov-2
and ov-1 respectively), and 5, 9, 10, 11, 12, 14 and 15
days after (ov+5, ov+9, ov+10, ov+11, ov+12, ov+14 and
ov+15 respectively) ovulation. For pregnant monkeys (n =
5), animals were permitted to mate over a period of 3 days
at the anticipated time of ovulation, the second day of
mating was designated day 0 of pregnancy. The presence
of a conceptus was confirmed by ultrasound diagnosis
and uterine tissue collected. At the appropriate time of
either the cycle (ov-3 to ov+15) or pregnancy (d22 or
d35), the monkeys were sacrificed humanely, the ovaries,
uterus, aorta, bladder, small intestine, skeletal muscle,
heart, liver and kidney were removed. AppropriatelyReproductive Biology and Endocrinology 2008, 6:22 http://www.rbej.com/content/6/1/22
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selected wedges of the ovaries and the uterus were fixed in
buffered formalin overnight at 4°C, washed in Tris-buff-
ered saline (pH 7.4) (TBS) and processed to paraffin wax
blocks. The remaining sections of the ovary and the uterus
and all other tissue types were collected in RNA later
(Ambion, CA, US) and stored at -80°C for RNA extrac-
tion.
RNA extraction, purification and quantitation
RNA was extracted from adult monkey tissue by homoge-
nisation in Trizol reagent (Qiagen Sciences, MD) accord-
ing to the manufacturer's instructions. All samples were
treated with RNase-free DNase (Ambion) and the concen-
tration and purity assessed by spectrophotometry and aga-
rose gel electrophoresis.
Reverse transcription and traditional PCR
Total RNA (1 ug) was reverse transcribed as previously
described [9]. A 2 μl aliquot of RT product was amplified
in a total volume of 25 μl using 2 × PCR-Master mix with
added magnesium (Promega) and 10 pmol sense and
antisense primers for long and short form HTRA3 and 18S
rRNA as outlined in Table 1. Primers for long form HTRA3
were designed to specifically amplify exons 9 and 10,
therefore amplifying exons specific to the long form and a
region that spans an intron (Fig 1). Primers for short form
HTRA3 were designed to amplify a region of exon 7, an
exon specific to the short form HTRA3 (Fig 1). PCR was
performed using a conventional PCR block cycler (Hybaid
PCR Express) with an annealing temperature of 58°C or
53°C for 30 cycles for the long form and the short form of
HTRA3 respectively. Cycle numbers in the linear phase
were used and 18S (with an annealing temperature of
58°C for 20 cycles) was used as a control. PCR products
were analysed by electrophoresis on a 1% (w/v) agarose/
TBE gel and bands visualised via ethidium bromide stain-
ing. The bands were excised and the identity of each PCR
product was also verified by DNA sequencing in initial
experiments.
Immunohistochemistry
Five-micron serial sections of ovarian and uterine tissue
were subjected to standard immunohistochemistry. All
ovarian sections underwent immunostaining in a single
experiment as did all uterine sections. For each section of
tissue, a serial tissue section was used as a negative con-
trol. Following antigen retrieval by microwaving the sec-
tions for 5 min in 0.1 M citric acid buffer (pH 6.0), the
endogenous hydrogen peroxidase activity was quenched
by incubating the sections with 3% H2O2. For the ovarian
tissue, non-specific binding was blocked by pre-incuba-
tion with a blocking buffer containing high salt TBS (0.3
M NaCl in 50 mM Tris, pH 7.6), 0.1% Tween 20, 15% rab-
bit serum and 2% normal human serum for 1 h at room
temperature. A similar blocking buffer and method was
used for the uterine tissue except 12% rabbit serum and
6% fetal calf serum were used in the buffer. The primary
antibody [sheep anti-HTRA3 antibody #153 [7] (2 μg/ml
for ovarian tissue, 0.5 μg/ml for uterine tissue) or pre-
immune sheep IgG as a negative control, at the same con-
centration as the primary antibody] was incubated in a
blocking buffer containing high salt TBS, 0.1% Tween 20,
10% rabbit serum and 2% normal human serum at 37°C
for 1 h and washed with high salt TBS plus 0.6% Tween.
The secondary antibody [#BA-6000, biotinylated rabbit
anti-sheep IgG (1:200, Vector Laboratories, Burlingame,
CA)] was applied in the same blocking buffer as the pri-
mary antibody for 30 min at room temperature. Positive
immunostaining was revealed by incubating the sections
with an avidin-biotin-complex conjugated to horseradish
Table 1: Primer sequences used for block RT-PCR analysis of 
HTRA3
Primer Sequence (5' to 3')
HTRA3-L F ATG CGG ACG ATC ACA CCA AG
R CGC TGC CCT CCG TTG TCT G
HTRA3-S F GAG GGC TGG TCA CAT GAA GA
R GCT CCG CTA ATT TCC AGT
18S F CGG CTA CCA CAT CCA AGG AA
R GCT GGA ATT ACC GCG GCT
HTRA3-L, long form HTRA3 mRNA; HTRA3-S, short form HTRA3 
mRNA.
F, forward primer; R, reverse primer
Alternative splicing of the HTRA3 gene and strategy to ana- lyze the two transcripts by RT-PCR Figure 1
Alternative splicing of the HTRA3 gene and strategy 
to analyze the two transcripts by RT-PCR. A schematic 
illustration of the alternative splicing of the HTRA3 gene to 
show how the long and the short transcripts are generated 
and analyzed. ATG, start codon; TGA, stop codon. Fragment 
HTRA3-L, amplified by HTRA3-L F (forward) and HTRA3-L R 
(reverse) primers listed in Table 1, across exon 9 and 10, 
represents the long specific transcript; fragment HTRA3-S, 
amplified by HTRA3-S F (forward) and HTRA3-S R (reverse) 
primers listed in Table 1, located on exon 7, represents the 
short specific transcript.
Short
mRNA
Long
mRNA
ATG TGA TGA
1 23 4 5 1 0 7 8 6 9
12 3 4 5 6 8 9 1 0
12 34 5 6 7
HTRA3-L
HTRA3-SReproductive Biology and Endocrinology 2008, 6:22 http://www.rbej.com/content/6/1/22
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peroxidase (DakoCytomation, Botany, Australia) in the
dark for 30 min at room temperature, followed by the
application of the peroxidase substrate 3,3'-diaminoben-
zidine (DakoCytomation) leading to a brown precipitate.
The sections were counterstained with Harris hematoxy-
lin. Microscopy was performed using an Olympus BH2
microscope fitted with a Fujix HC-2000 high resolution
digital camera (Fujix, Tokyo, Japan).
To determine the expression level and cellular localization
of HTRA3 protein in the non-pregnant ovary, ovaries col-
lected at ov-3, ov-2, ov+5, ov+9, ov+11, ov+12 and ov+14
were examined (n = 1 monkey for each day). Follicles
were counted and investigated from all 7 monkeys (pri-
mordial follicles, n = 158; primary follicles, n = 119; sec-
ondary follicles, n = 78; late secondary follicles, n = 4;
antral follicles, n = 5 (antral follicles were observed in
monkeys at ov-3 and ov-2), corpora lutea, n = 3 (CLs were
observed in monkeys at ov+11, ov+12 and ov+14). Non-
pregnant uterine tissues sampled at ov-1 (n = 3), ov+5 (n
= 3), ov+10 (n = 3) and ov+15 (n = 2) of the menstrual
cycle were also examined. The relative intensity of the
immunostaining was scored semiquantitatively by two
independent observers; zero representing no staining and
four representing maximal staining. Such analysis of
immunostaining has previously been reported [10,11].
The scores for each type of cellular subtype in each differ-
ent follicle type investigated by each observer were then
averaged. Comparisons of staining intensities between
cellular subtypes within different follicle types were per-
formed using One-way ANOVA, followed by Tukey's post
hoc test using PRISM v4 for Windows (GraphPad Software
Inc, San Diego, CA). The staining intensity of the endome-
trial glandular epithelium of non-pregnant monkeys at
different stages of the cycle was scored and analysed in a
similar fashion, with the quantitation resulting in the
average of the signal. P < 0.05 was considered statistically
significant.
The expression of HtrA3 at the maternal-fetal interface
was determined by examining implantation sites (includ-
ing the uterus and the placenta) from d22-d35 pregnant
monkeys (n = 5). For these tissues, trophoblast cells were
identified by immunostaining for cytokeratin using a
mouse anti-human cytokeratin monoclonal antibody (7
μg/ml, #34902, BD Biosciences, San Jose, CA) as the pri-
mary and a biotinylated horse anti-mouse IgG (1:200,
#BA-200, Vector Laboratories) as the secondary antibody,
following antigen retrieval as for immunostaining of
HtrA3.
Results
Expression of HTRA3 mRNA in adult rhesus monkey tissue
Using RT-PCR, the long and short forms of HTRA3 mRNA
were detected in the ovary, aorta, bladder, small intestine,
skeletal muscle, heart and uterus but not the liver nor the
kidney (Fig 2). The long form HTRA3 mRNA product size
was 337 base pairs (bp) while the short form HTRA3
mRNA was 320 base pairs. The highest level of the long
form HTRA3 mRNA was in the ovary, heart and uterus
(Fig 2). The highest expression of short form HTRA3
mRNA was in the ovary and bladder (Fig 2). 18S  was
detected in all adult rhesus monkey tissues investigated
(Fig 2). The RNA extracted from ovaries at each stage of
the cycle was analysed by traditional RT-PCR, however
there was no difference in the expression of either the long
form HTRA3 or the short form HTRA3 between the differ-
ent stages (data not shown).
Localization of HTRA3 protein in the ovary of non-
pregnant rhesus monkey
Primordial follicles (Fig 3A) showed staining in the
oocyte, however the squamous granulosa cells surround-
ing the oocyte were negative for HTRA3 protein. A similar
pattern was seen in the primary follicles (Fig 3B arrow-
head). The newly forming thecal cells surrounding the
granulosa cells were negative for HTRA3 (Fig 3B arrow).
Expression of HTRA3 protein began to increase in the sec-
ondary follicles with the granulosa cells (Fig 3C arrow-
head) showing moderate staining for HTRA3 whilst the
thecal cells showed no staining (Fig 3C arrow). When the
intensity of staining in the granulosa cells was scored,
there was no significant difference between primordial
and primary and secondary follicles (Fig 4A and 4B).
HTRA3 protein expression in the granulosa cells signifi-
cantly increased (P < 0.05) from primordial and primary
HTRA3 mRNA expression in various adult rhesus monkey tis- sues Figure 2
HTRA3 mRNA expression in various adult rhesus 
monkey tissues. Amplification of long HTRA3 (HTRA3-L), 
short HTRA3 (HTRA3-S) mRNA and 18S rRNA in rhesus 
monkey ovary, aorta, bladder, small intestine, skeletal mus-
cle, heart, liver, kidney and uterus. The PCR product size 
(bp) for each transcript is indicated.
18S (187bp)
HTRA3-S (320bp)
HTRA3-L (337bp)
Ovary
Aorta
Bladder
Small Intestine
Heart
Liver
Kidney
Uterus
Skeleton MuscleReproductive Biology and Endocrinology 2008, 6:22 http://www.rbej.com/content/6/1/22
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follicles to the cumulus and mural granulosa cells of the
late secondary follicles (Fig 3D and Fig 4A and 4B). The
thecal cells remained negative. A significant increase in
the intensity of granulosa cell staining for HTRA3 protein
was observed in the antral follicles (Fig 3E and 4A and
4B). HTRA3 protein in both the cumulus and the mural
granulosa cells was significantly higher in antral follicles
than in primordial and primary follicles (P < 0.01), and
secondary follicles (P < 0.05) (Fig 4A and 4B). The cumu-
lus granulosa cells in the antral follicles (Fig 4A) showed
more intense staining for HTRA3 compared to the mural
granulosa cells (Fig 4B). The thecal cells of antral follicles
were negative for HtrA3 protein. In the CL the granulosa-
lutein cells (Fig 3F arrows) showed significantly (P < 0.01)
higher expression of HTRA3 protein than the theca-lutein
cells (Fig 3F asterisk and 4D).
High expression of HTRA3 protein was observed in the
oocytes of all follicles. This level of expression was not sig-
nificantly different between follicle types (Fig 3A-E and
Fig 4C).
Localization of HTRA3 protein in the endometrium of non-
pregnant/non-mated rhesus monkey
In the non-pregnant monkey endometrium, HTRA3 was
detected primarily in the glandular epithelium at all
examined stages of the cycle (Fig 5A–G,). Within each
sample, however, not all glands were stained with equal
intensity, rather zonal variations in staining were
observed. In general, glands close to the myometrium
were stained stronger than those close to the uterine
lumen (Fig 5A and 5D). To take this difference within
each sample into consideration when comparing different
samples, we arbitrarily divided the glands on each section
into two groups (outer and inner) according to their loca-
tion and scored separately. The outer glands were defined
as those located in the upper two-thirds of the
endometrium near the lumen known as the functionalis
and the inner glands in the lower third of the
endometrium near the myometrium known as the basalis.
In all sections examined, the basalis glands on average,
stained more strongly than the functionalis glands (Fig 5B
and 5C, F and 5G, and Fig 6). When different stages of the
cycle were compared, the two groups of glands showed a
very similar trend of immunostaining: lower intensity at
ov-1 (Fig 5B–C, Fig 6), higher at ov+5 and maximal at
ov+10 (Fig 5F–G, Fig 6), but then decreasing again at
ov+15 (Fig 6). Statistical analysis, however, did not reveal
these differences to be significant.
Localization of HTRA3 at rhesus monkey implantation 
sites
The earliest implantation site available was on day 22 and
the latest on day 35 of pregnancy. HTRA3 staining pattern
was the same between these days and an implantation site
on day 35 is shown (Fig 7A). Both maternal decidual cells
(Fig 7A and 7C) and glands (Fig 7D) were strongly stained
for HtrA3 during pregnancy. In contrast, trophoblast cells,
which were positively identified by their staining for
cytokeratin (Fig 7B), showed weak staining for HTRA3
depending on the subtypes (Fig 7A). Trophoblast shell
was completely negative for HTRA3 (Fig 7C), so were
most of the cells in the trophoblast cell columns in the
anchoring villi (Fig 7E). On the other hand, the syncytial
trophoblast on the exterior of the anchoring (Fig 7E) and
the floating (Fig 7F) villi was positive. Some but not all
villous cytotrophoblast was positively stained for HTRA3,
the intensities were generally weaker than in the adjacent
syncytiotrophoblasts (Fig 7F).
A few blood vessels in the decidua close to the trophoblast
shell were surrounded by a thick rim of large number of
extravillous cytotrophoblasts (EVTs) which stained
strongly for cytokeratin (Fig 7G, asterisks). The wall of
such blood vessels could no longer be clearly defined, and
it was apparent that some trophoblast cells had replaced
the endothelium (Fig 7G, arrow) and some were inside
the vessel (Fig 7G, arrowhead). When serial sections were
immunostained for HTRA3, the EVTs outside the blood
vessel were negative (Fig 7H, asterisk), whereas those lin-
ing or inside the vessel (Fig 7H, arrow and arrowhead
respectively) were weakly positive. Except those EVTs that
were closely associated with blood vessels, no interstitial
EVTs distributed away from blood vessels was identified
on our sections.
Discussion
This study confirmed a correlation between firstly, HTRA3
during folliculogenesis and luteinisation in the rhesus
monkey ovary, and secondly between endometrial func-
tion and the maternal-fetal interface during early preg-
nancy in the rhesus monkey.
A significant increase in HTRA3 protein expression from
primordial and primary follicles through to antral follicles
was observed in granulosa cells with the exception of
theca cells. This increase in HTRA3, particularly in the
granulosa cells, with the maturation of follicles is similar
to that seen in the rat [5] and indicates that HTRA3 is asso-
ciated in the process of folliculogenesis not only in
rodents, but also in primates.
Both the cumulus cells surrounding the oocyte and the
mural granulosa cells lining the follicle wall of late sec-
ondary and antral follicles showed significant upregula-
tion of HTRA3, however the cumulus granulosa cells
stained more strongly for the protein. An important stage
in the maturation of follicles is the division of granulosa
cells into cumulus and mural cells. Several factors are
involved in this differentiation step including members ofReproductive Biology and Endocrinology 2008, 6:22 http://www.rbej.com/content/6/1/22
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HTRA3 protein immunolocalisation in the adult rhesus monkey ovary Figure 3
HTRA3 protein immunolocalisation in the adult rhesus monkey ovary. Representative photomicrographs of HTRA3 
immunolocalisation in follicular sub-populations in adult rhesus monkey ovary. A, primordial follicles with insert of negative 
control; B, primary follicles with granulosa cells highlighted by the arrowhead and newly forming thecal cells by the arrow; C, 
secondary follicle, granulosa cells highlighted by arrowhead and thecal cells by arrow; D, late seondary follicle; E, antral follicle; 
F, granulosa-lutein cells (arrow) and theca-lutein cells marked by asterisk (*) of newly forming CL. Scale bar = 50 μm
A
F E
D C
B
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Intensity of staining for HTRA3 protein in the adult rhesus monkey ovary Figure 4
Intensity of staining for HTRA3 protein in the adult rhesus monkey ovary. Mean density (± SEM) of HTRA3 immu-
nostaining in the monkey ovary. A, cumulus granulosa cells; B, mural granulosa cells; C, oocytes; D, luteinising cells of the CL. 
Prim, primordial follicle (n = 158); PF, primary follicle (n = 119) (Prim + PF, n = 277); SF, secondary follicle (n = 78); LSF, late 
secondary follicle (n = 4); Ant, antral follicle (n = 5); GLC, granulosa-lutein cells; THLC, theca-lutein cells (n = 3 CL). ** P < 
0.01, *P < 0.05.
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the transforming growth factor-β (TGF-β) superfamily. In
the mouse, lack of oocyte derived bone morphogenetic
protein-15 (BMP-15) results in defective cumulus cell dif-
ferentiation and cumulus expansion [12,13]. Follicles fail
to progress beyond the late secondary stage in the absence
of oocyte derived growth differentiation factor-9 (GDF-9)
[14,15]. Consequently it is clear that the cumulus cells are
involved in promoting oocyte growth and developmental
competence through bidirectional interactions with the
oocyte [13,16]. HTRA3 is a newly identified protein [3,4]
and its function is still unclear. Supporting a possible role
for HTRA3 protease action in the differentiation of granu-
losa cells into cumulus and mural cells is the report that
HTRA3 can bind to various TGF-β superfamily members
and can inhibit the signalling of BMP-4, BMP-2 and TGF-
β 1 [17]and that HTRA3 protein was upregulated in the
cumulus granulosa cells and the oocyte of antral follicles
in the rat ovary [5] and in the primate in the current study.
HTRA3 may also be involved in the formation of a local
extracellular matrix (ECM) by the cumulus cells which
envelopes the cumulus oocyte complex (COC). This proc-
ess plays a vital role in ovulation [18,19]. HTRA3 exhibits
substrate specificity toward β-casein and certain ECM pro-
teoglycans [17] implying that HTRA3 may directly modu-
HTRA3 protein immunolocalisation in the endometrium Figure 5
HTRA3 protein immunolocalisation in the endometrium. A, ov+5, the side of the basalis glands is presented on the 
bottom of the image. B-C, functionalis (B) and basalis (C) glands of (A) at a higher magnification. D, ov+10, tissue orientation 
same as A. E, negative control whereby pre-immune sheep IgG was used as the primary antibody on an adjacent section of D. 
F-G, functionalis (F) and basalis (G) glands shown of (D) at a higher magnification.
AB
C
DE F
G
Basalis
Functionalis
Intensity of staining for HTRA3 protein in the endometrial  glands of non-pregnant, non-mated rhesus monkeys Figure 6
Intensity of staining for HTRA3 protein in the 
endometrial glands of non-pregnant, non-mated rhe-
sus monkeys. Mean density (± SEM) of HtrA3 immunos-
taining in endometrial glands (basalis and functionalis 
respectively). ov, ovulation; ov-1, one day before ov; ov+5, 
ov+10 and ov+15, 5, 10 and 15 days after ov respectively. n = 
3 for all stages except for ov+15 (n = 2).
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late the ECM microenvironment of the COC to facilitate
ovulation.
High expression of HTRA3 was seen in the granulosa-
lutein cells of the CL implying a role for this serine pro-
tease in luteinisation. This is supported by the localisation
of HTRA3 in the rat CL [5]. A large number of proteinases
involved in folliculogenesis and luteinisation are found in
the CL. Proteoglycans such as decorin have been found in
bovine CLs [20]. Decorin is a well known modulator of
the ECM and recombinant HTRA3 can degrade ECM pro-
teins such as decorin [17,21]. This suggests a role for ovar-
ian derived HTRA3 in the regulation of the ECM
microenvironment of the CL for the process of luteinisa-
tion.
In addition, oocytes in all follicles stained positive for
HTRA3 protein. In most species, including humans,
oocyte health, follicle growth and ovulation are depend-
ent on some level of oocyte derived TGF-β superfamily
members [22,23]. As HTRA3 is reported to be able to bind
to a broad range of TGF-β superfamily members and
inhibit TGF-β signalling [17,24], and the present study
has shown that HTRA3 is expressed in similar cells in the
HTRA3 immunolocalisation at the maternal-fetal interface Figure 7
HTRA3 immunolocalisation at the maternal-fetal interface. A, a low power view of an implantation site. C, a higher 
power view of A showing the decidual-trophoblast shell junction. D, maternal glands. E, anchoring villi, F, floating villi. Cytoker-
atin staining in implantation sites is shown in panels B and G. B, an adjacent section of A stained for cytokeratin; G, extravillous 
endovascular trohoblasts (EVTs) surrounding a blood vessel stained for cytokeratin; EVTs outside the vessel are highlighted by 
asterisks (*), and those lining and inside the vessel by the arrow and arrowhead respectively. H, an adjacent section of G 
stained for HTRA3. Deci, decidual cells; t, trophoblast cells; ts, trophoblast shell; ge, glandular epithelium; cc, trophoblast cell 
column. Scale bar = 50 μm.
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ovary as TGF-β superfamily members (for a review see
[25]), it is possible that HTRA3is involved in the mainte-
nance of the health of oocytes.
During the rhesus monkey menstrual cycle, HTRA3 was
localised primarily in the endometrial glands. Interest-
ingly expression of HTRA3 protein in these glands
increased 5 days following ovulation and was maximal 10
days after ovulation. During this secretory phase of the
cycle in the primate, the endometrium prepares for mater-
nal-trophoblast interaction should fertilisation occur. Fol-
lowing implantation, HTRA3 was expressed strongly in
the glands and decidual cells.
The high expression of HTRA3 protein in both the mater-
nal decidual cells and the glands during early pregnancy
correlates with previous findings in the human. HTRA3
was in particular significantly upregulated during first-tri-
mester pregnancy when decidualisation is fully advanced
and is also increased as stromal cells decidualise in vitro
[7]. Many growth factors and ECM proteins produced by
the decidua regulate trophoblast proliferation, differenti-
ation and invasion. It has been shown that HTRA3 and
HTRA1 are able to degrade a number of ECM proteins
[17,21]. It is therefore possible that HTRA3 is directly
involved in the decidua ECM microenvironment, assisting
trophoblast invasion. In addition, strong expression of
TGF-β superfamily members has been reported in the
decidua [26] and these decidual TGF-βs have been dem-
onstrated to be able to inhibit trophoblast invasion via
paracrine manners [26]. This suggests that in the decidua,
HTRA3 may inhibit TGF-β signalling, thereby regulating
trophoblast migration and invasion.
During early pregnancy, HTRA3 expression was also
detected in synctiotrophoblasts and endovascular EVTs in
the rhesus monkey. This is consistent with studies
reported in the human [7]. However, expression of
HTRA3 in the trophoblast shell was below detection in
the rhesus monkey in contrast to that seen in the human
[7]. This may highlight the variation between the rhesus
monkey and the human.
Both the rodent and the human HTRA3 and HTRA1 pro-
tein sequences include an IGF binding domain at the N-
terminus [3,27] suggesting that these serine proteases may
be involved in the IGF/IGFBP system. Indeed, it has been
reported that HTRA1 cleaves IGFBP-5 and that the inhibi-
tion of its protease activity suppresses IGF-I action [28].
The IGF/IGFBP system is vital in modulating the mater-
nal-fetal interface for the establishment and maintenance
of pregnancy and all components of the system are
expressed in the endometrium/decidua or placenta at var-
ious stages of pregnancy in all species [29-31]. An impor-
tant factor in the co-ordination of the IGF/IGFBP system
is proteolysis of IGFBPs leading to increased IGF bioactiv-
ity [32,33]. It is thus possible that HTRA3 may be capable
of modulating the IGF/IGFBP system particularly during
placentation. Further studies are required to elucidate the
precise molecular mechanisms of HTRA3 during this
process.
Conclusion
This study has demonstrated a clear association between
HTRA3 expression and folliculogenesis and luteinisation
in the rhesus monkey ovary. In addition we have reported
a dynamic correlation between HTRA3 and endometrial
function at the maternal-fetal interface during early preg-
nancy in the rhesus monkey supporting previous findings
in the human [7]. These results suggest a role for HTRA3
in primate female reproduction. In order to determine the
mechanisms of HTRA3 in female reproduction, the next
vital step in research is to determine HTRA3 substrate spe-
cificity.
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